Epigenica Closes $2.2 Million Investment Round to Scale Cutting-Edge Epigenetic Solutions

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market

This website uses cookies. By continuing to use this site, you accept our use of cookies.